Considering the role of Dyrk1A in neuronal progenitor proliferation, neurogenesis, and neurodifferentiation, it has been suggested that molecules targeting this gene could provide therapeutic benefits to DS phenotypes. The gene discussed is DYRK1A; the disease is Dravet syndrome.